Which TAA Strategies Actually Work in Europe: A UCITS Substitution Guide

The wall every European TAA investor hits

A European retail investor opens IBKR, finds HAA on BestFolio, and clicks through to implement it. The strategy wants SPY, IWM, VWO, VEA, QQQ, IEF, TLT, DBC and VNQ, plus a canary in TIP and a defensive parking spot in BIL. Every one of those tickers is US-domiciled, and none of them are buyable.

The block sits at the regulator. PRIIPs requires a Key Information Document, in an official language of the country where the fund is sold, for any product offered to EU retail, and US ETF issuers do not produce one. The result is that the most-cited TAA strategies are designed around a universe European retail clients cannot access through normal channels. (Investors who qualify as elective professional clients can sometimes step around this, but that is a separate route most readers are not on.)

The workaround is UCITS substitution. Every US sleeve gets mapped to a UCITS ETF that holds roughly the same exposure, listed on XETRA, Borsa Italiana or the LSE, and tradeable through any EU broker. The question is how clean that substitution actually is, and the honest answer is that it depends heavily on the strategy.

What "clean substitution" actually means

Three criteria, all of which matter and all of which get conflated when people say "the European version":

• Asset class match. S&P 500 for S&P 500, long treasuries for long treasuries. This is the criterion most discussions stop at.
• Methodology match. Cap-weighted versus cap-weighted, value-composite versus value-composite, total-market versus a screened subset. Two ETFs can both say "small cap value" and hold meaningfully different baskets.
• Liquidity match. The substitute has to absorb a TAA-sized order without painful spreads. A wide bid-ask on a monthly rebalancer quietly compounds into real CAGR drag.

The Tier 1 strategies below clear all three. Tier 2 clears one or two. Tier 3 does not really clear any of them, which is fine as long as you know it going in.

Tier 1: the strategies that translate cleanly

These run on universes with one-to-one UCITS substitutes and deep XETRA or LSE liquidity. If you are starting from zero in Europe, start here.

The concrete substitutes below are all issuer-confirmed as of July 2026. Expense ratios are the issuers' stated figures; several houses offer a comparable fund for most of these, so treat the ticker as an example rather than an endorsement.

• SPY: CSPX (iShares Core S&P 500 UCITS, IE00B5BMR087), TER 0.07%, accumulating
• QQQ: CNDX (iShares Nasdaq 100 UCITS, IE00B53SZB19), TER 0.30%
• IEF (7-10yr): IDTM, the USD line of the iShares $ Treasury Bond 7-10yr UCITS (IE00B1FZS798), TER 0.07%
• IEI (3-7yr, for All Weather): CBU7 (iShares $ Treasury Bond 3-7yr UCITS, IE00B3VWN518), TER 0.07%
• TLT (20+yr): DTLA (iShares $ Treasury Bond 20+yr UCITS, IE00BFM6TC58), TER 0.07%, accumulating; a distributing line trades as IDTL
• AGG: IUAG (iShares US Aggregate Bond UCITS, IE00B44CGS96), TER 0.25%. Note this is a US aggregate fund, matching AGG. The similarly named iShares Core Global Aggregate (AGGG, IE00B3F81409, 0.10%) is a different, broader exposure, so do not swap one for the other by name alone.
• GLD: IGLN (iShares Physical Gold ETC, IE00B4ND3602, also listed as SGLN), TER 0.12%. Technically an ETC rather than a UCITS fund, but UCITS-eligible and the standard European gold sleeve.
• BIL: IB01 (iShares $ Treasury Bond 0-1yr UCITS, IE00BGSF1X88), TER 0.07%. This keeps USD T-bill exposure for strategies that need it. If you would rather hold EUR cash, XEON (Xtrackers II EUR Overnight Rate Swap, LU0290358497, 0.10%) or CSH2 (Amundi Smart Overnight Return, LU1190417599, 0.10%) both track compounded €STR, at the cost of the currency shift.

The friction in this tier is mostly invisible, and in one respect the European setup is arguably cleaner. CSPX is accumulating, so there is no dividend payout to reinvest and no withholding cascade, and it is Irish-domiciled, so US dividends inside the fund face 15% withholding via the treaty with no second EU layer. (Holders of US-situs ETFs also carry US estate-tax exposure above roughly $60,000, which an Irish UCITS avoids. That is a footnote for accumulation, but it matters for larger balances.) A European running GEM or the Permanent Portfolio through these tickers often ends up with a tidier structure than the US original.

One caveat that applies to this whole tier rather than to any single sleeve: CSPX, DTLA, IDTM, IB01 and a US-TIPS fund all leave a euro investor with USD exposure on the underlying. That is inherent to substituting a US asset, not a defect of any one fund, and it applies equally to the inflation sleeve discussed below.

Tier 2: viable, but you lose some character

Here the substitute is real but it is not exactly the same fund. The compromise lives in the methodology, not the asset class.

Small-cap value (AVUV, IWN, IJS, VBR). Two honest routes. Route one is AVWS (Avantis Global Small Cap Value UCITS, IE0003R87OG3, TER 0.39%, listed on XETRA and the LSE, launched September 2024). It runs the same Avantis profitability-and-value process, but its universe is global developed rather than US-only, so an AVUV sleeve loosens into something broader. Route two is ZPRV (SPDR MSCI USA Small Cap Value Weighted, IE00BSPLC413, TER 0.30%), which keeps the US-only universe but switches to MSCI value-composite weighting and drops the profitability screen. On monthly total returns in a common currency, AVUV and ZPRV have run around 0.97 correlated, and the realised gap between them has averaged a little over one point of CAGR a year, though in individual years it has swung from about minus seven to plus six points. For a small sleeve that is a fair trade; for a load-bearing 30%-plus allocation, the year-to-year tracking difference is large enough to change the strategy's character.

A ticker-hygiene note, because this one causes real mistakes: Avantis added a US-focused UCITS, the Avantis America Equity UCITS ETF (IE000OW54ZX1), only in February 2026, and its exchange ticker AVUS collides with the older US-domiciled Avantis U.S. Equity ETF (US0250728856). They are different funds in different wrappers. Always confirm the ISIN.

US REIT (VNQ). The closest UCITS is IUSP (iShares US Property Yield UCITS, IE00B1FZSF77, TER 0.40%). It is genuinely different, not just thinner: IUSP applies a dividend-yield screen that VNQ does not, and the two have diverged by several points of CAGR a year historically. Usable for a small sleeve with limit orders, but treat it as a related exposure rather than a clone.

Developed ex-US large cap (VEA, VEU, EFA). EXUS (Xtrackers MSCI World ex USA UCITS, IE0006WW1TQ4, TER 0.15%) is a genuine developed-ex-US fund and the cleanest match here. One caveat: it launched in March 2024, so its own live history is short. Watch for EUNL as a substitute here, because it is iShares Core MSCI World, which is roughly 72% US as of mid-2026 and therefore not an ex-US fund at all.

Developed ex-US small cap (SCZ). No single clean match. ZPRX (SPDR MSCI Europe Small Cap Value Weighted, IE00BSPLC298) covers the European slice but holds no Japan or Pacific, so pairing it with a broad ex-US fund only approximates SCZ. Workable, but it is a construction rather than a substitution.

Tier 3: no clean substitute exists

These are the sleeves where the honest answer is that the European version is a different exposure.

Diversified commodity (DBC, PDBC). UCITS rules bar a fund from holding physical commodities or commodity futures directly, which is why every European commodity ETF here is swap-based rather than a rule about roll schedules. The usable substitutes are ICOM (iShares Diversified Commodity Swap UCITS, IE00BDFL4P12, 0.19%) and CMOD, the USD line of the Invesco Bloomberg Commodity UCITS (IE00BD6FTQ80, 0.19%); both track the Bloomberg Commodity Index via swap and are what our own UCITS mapping points to. WisdomTree's Enhanced Commodity range (WCOA and siblings) uses a more active roll, but note that its all-in cost is closer to 0.70% a year once the swap fee is added to the 0.35% headline TER, so it is not the cheap option it looks like. Against a US DBC sleeve, expect a broad-commodity UCITS to track loosely, on the order of a point or more of annual drift over a full cycle.

US TIPS (TIP). This one is actually a clean asset-class match, and the earlier version of this guide got it wrong by demoting it. ITPS (iShares $ TIPS UCITS, IE00B1FZSC47, 0.10%) holds the same US inflation-linked bonds as TIP. The only wrinkle is the USD exposure a euro investor picks up on the principal, and as noted above that same wrinkle applies to every USD sleeve in Tier 1, so it is not a reason to single out the inflation sleeve. Do not confuse ITPS with IBCI (iShares € Inflation Linked Govt Bond UCITS, IE00B0M62X26, 0.09%): IBCI holds eurozone linkers, which is a genuinely different asset, not a US-TIPS substitute. Currency-hedged US-TIPS share classes exist if you want to remove the FX, at a modest cost.

Active or thematic alpha sleeves (mortgage REITs like REM, leveraged single-factor ETFs, K-1 commodity partnerships). Mostly unavailable in UCITS form. If your broker forces you onto UCITS, these strategies are the ones to skip rather than approximate.

The XETRA reality: even a clean substitute has a spread

Bid-ask matters more for TAA than for buy-and-hold. A buy-and-hold investor pays the spread twice in a lifetime. A monthly rotation with, say, 200% annual turnover pays it on the order of four times a year (two round trips), and on thin small-cap or REIT UCITS lines a wide round-trip spread adds up on top of the TER. Look up the recent spread and daily volume on the actual substitute before you commit, not just the headline fee. The TER is what gets quoted; the spread is the part you actually pay at rebalance.

A practical rule: use limit orders on any sleeve that trades thinly on your exchange, and accept that on a fast-moving rebalance day you may not get filled at your price. Monthly rebalancers tolerate this. Daily or weekly ones do not.

Where this leaves the catalog

Across the 82 strategies in the BestFolio catalog, substitution friction sorts roughly into three groups:

• Green: GEM, Permanent Portfolio, Classic 60/40, and large-cap-only momentum variants. Translates to UCITS with negligible drift.
• Yellow: Anything leaning on a small-cap-value sleeve, developed-ex-US small cap, or a meaningful REIT weight. Workable, but expect the European version to drift from the US backtest, sometimes by more than a point of CAGR a year.
• Red: Anything depending heavily on active commodity exposure, or reaching for an AVUV-family fund as a load-bearing sleeve. Implementable, but the European version is a meaningfully different strategy.

Build Green first, then Yellow with your eyes open, then Red only once you understand what changes.

What we built to make this less painful

The UCITS Finder maps every US ticker referenced in the catalog to its closest UCITS substitute, returning the ticker, fund name, ISIN, listing symbols, a confidence label (exact, close, or approximate) and a note on how the exposure differs. On a strategy detail page, toggling the UCITS view rewrites the asset-universe card to show the European substitutes and their liquidity, so you can see at a glance which sleeves are clean and which are approximations. The tool does not re-run the backtest against the substitute basket; the substituted funds diverge from the US originals in ways a single blended number would hide, and the per-sleeve view is the more honest output anyway.

The feedback that triggered this writeup came from a European tester. The underlying point is that most European TAA discussion online stops at "AVUV has no UCITS clone", as if that one fact settled the question. What was missing was a per-strategy view of how much of the original you actually keep through the substitution chain. The implementation gap lives in that gradient, not in any single ticker.